CLINICAL_TRIALS
trial_result
· 2022-02-03
Clinical Trial Update: Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome [Phase 3]
Summary
Phase 3 trial evaluating liraglutide for weight management in pediatric Prader-Willi syndrome completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2022-02-03